Gheuens Sarah
SEC insider (Form 3/4/5 filer). CIK 0001881190. Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO) and 1 other issuer. 45 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in CAMBRIDGE, MA.
Companies Gheuens Sarah has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Officer, Chief Medical Officer
- Viridian Therapeutics, Inc.\DE (VRDN): Director
Gheuens Sarah
CIK: 0001881190
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (45 total)
- Oct 22, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect500 shares at avg. $25.01$13K - Oct 22, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect500 shares at avg. $37.52$19K - Oct 21, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect1.5K shares at avg. $37.53$56K - Oct 21, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect1.5K shares at avg. $25.01$37K - Aug 4, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect30K shares at avg. $30.48$914K - Jul 1, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
32.3K shares- - Jul 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect8.4K shares- - Jul 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect4K shares at avg. $37.56$151K - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirectPerformance share units
3K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 500 | $25.01 | $12,505 | Direct |
| Oct 22, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 500 | $37.52 | $18,760 | Direct |
| Oct 21, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 1,489 | $37.53 | $55,882 | Direct |
| Oct 21, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 1,489 | $25.01 | $37,240 | Direct |
| Aug 4, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 30,000 | $30.48 | $914,400 | Direct |
| Jul 1, 2026 |  VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 32,341 | - | - | Direct |
| Jul 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 8,375 | - | $0 | Direct |
| Jul 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 4,007 | $37.56 | $150,503 | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise Performance share units | 3,000 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 3,000 | - | - | Direct |
1-10 of 45 transactions